Psoriasis Clinical Trials in San Antonio

Showing 121-140 of 155 trials

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

NCT02630901

This multiple ascending dose study is to determine safety, tolerability, pharmacokinetics and immunogenicity of PRX003 in approximately 56 patients with Psoriasis.

Psoriasis

Prothena Biosciences Limited48 participantsStarted Mar 2016

San Diego, California, United States • Coral Gables, Florida, United States • Ocala, Florida, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

NCT02949388

This study is designed as a randomized, double blind, parallel group, placebo-controlled trial to study the efficacy and safety of two oral doses of Prurisol administered twice daily for twelve weeks to subjects with moderate to severe chronic plaque psoriasis.

Chronic Stable Plaque Psoriasis

Innovation Pharmaceuticals, Inc.199 participantsStarted Nov 2016

Glendale, Arizona, United States • Hot Springs, Arkansas, United States • Rogers, Arkansas, United States +31 more locations

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Psoriasis Trials in Other Cities

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Tofacitinib Ointment For Chronic Plaque Psoriasis

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis

A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis

Other Conditions in San Antonio